Statements (11)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:activeDuring |
various active compounds
|
| gptkbp:clinicalTrials |
completed
|
| gptkbp:date |
FDA_approved
|
| gptkbp:developedBy |
gptkb:OPKO_Health,_Inc.
|
| gptkbp:formulation |
injectable
|
| https://www.w3.org/2000/01/rdf-schema#label |
OPKO 2600
|
| gptkbp:marketedAs |
gptkb:United_States
|
| gptkbp:patentStatus |
patented
|
| gptkbp:route |
subcutaneous
|
| gptkbp:usedFor |
treatment of various medical conditions
|